All News

Primary care clinicians should be the first to prescribe SGLT2 inhibitors for many reasons, as explained by Prof Jonathan McMurray in this Patient Care interview.

DAPA-CKD investigator Professor John McMurray details the trial and renal and cardiovascular outcomes for Patient Care Online.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The United Kingdom became the first country to grant emergency use authorization for a vaccine to combat COVID-19.

COPD gets an early start, jury still out on nocturnal oxygen, breath test could distinguish COVID-19—scroll through these slides for concise summaries of the latest research findings.

Global confirmed cases of COVID-19 have surpassed 63 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Put some therapeutic comedy into your daily routine--study up with this slideshow of medical humor highlights from around the web.

The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.

Exacerbations of asthma and COPD have a negative impact on disease process in both conditions. Find out what you know about guideline-recommended mitigation.

US confirmed cases of COVID-19 have surpassed 13 million; global cases have reached 62 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Results of a new study suggest that remission of obesity-related complications in adolescents who underwent bariatric surgery is not dependent on sustained weight loss.

In episode 5 of Primary Viewpoints, Jonathan Chow, MD, reviews the landmark study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for death.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Pain specialist Steven King, MD, highlights a new review that looks at the complex, bidirectional relationship between sleep disturbance and chronic pain.

Global confirmed cases of COVID-19 have surpassed 59 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

The FDA issued an EUA for the investigational antibody cocktail casirivimab and imdevimab for the treatment of mild-to-moderate COVID-19 in high risk patients.

The AstraZeneca/Oxford vaccine candidate showed 90% efficacy in one dosing regimen; 62% in a second; and an average efficacy rate of 70%.

Prepare patients for a safe Thanksgiving with key CDC-based recommendations including alternative Thanksgiving activities, steps to take if exposed to COVID-19, and more.